» Articles » PMID: 20831787

Characterisation of COPD Heterogeneity in the ECLIPSE Cohort

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a complex condition with pulmonary and extra-pulmonary manifestations. This study describes the heterogeneity of COPD in a large and well characterised and controlled COPD cohort (ECLIPSE).

Methods: We studied 2164 clinically stable COPD patients, 337 smokers with normal lung function and 245 never smokers. In these individuals, we measured clinical parameters, nutritional status, spirometry, exercise tolerance, and amount of emphysema by computed tomography.

Results: COPD patients were slightly older than controls and had more pack years of smoking than smokers with normal lung function. Co-morbidities were more prevalent in COPD patients than in controls, and occurred to the same extent irrespective of the GOLD stage. The severity of airflow limitation in COPD patients was poorly related to the degree of breathlessness, health status, presence of co-morbidity, exercise capacity and number of exacerbations reported in the year before the study. The distribution of these variables within each GOLD stage was wide. Even in subjects with severe airflow obstruction, a substantial proportion did not report symptoms, exacerbations or exercise limitation. The amount of emphysema increased with GOLD severity. The prevalence of bronchiectasis was low (4%) but also increased with GOLD stage. Some gender differences were also identified.

Conclusions: The clinical manifestations of COPD are highly variable and the degree of airflow limitation does not capture the heterogeneity of the disease.

Citing Articles

Contrasting the clinical and biological characteristics of young and old COPD patients.

Vila M, Agusti A, Vestbo J, Celli B, Cosio B, Silverman E ERJ Open Res. 2025; 11(1).

PMID: 40008176 PMC: 11849125. DOI: 10.1183/23120541.00671-2024.


Clinical-Epidemiological Profile of Patients With Chronic Obstructive Pulmonary Disease Treated at the Pneumology Outpatient Clinic of a Brazilian University Hospital.

Sarno Filho M, Soares L, Lima Costa Neves M Cureus. 2024; 16(12):e75451.

PMID: 39677991 PMC: 11646360. DOI: 10.7759/cureus.75451.


The Effect of Patient Sex on Treatment Outcomes in COPD: A Post Hoc Analysis of the IMPACT Trial.

Alberola A, Nogal N, Miranda A, Lipson D, Tombs L, Han M Chronic Obstr Pulm Dis. 2024; 11(6):591-603.

PMID: 39531369 PMC: 11703016. DOI: 10.15326/jcopdf.2024.0541.


Experimental Mouse Models and Human Lung Organoid Models for Studying Chronic Obstructive Pulmonary Disease.

Joe Y, Lee M, Choi H Biomol Ther (Seoul). 2024; 32(6):685-696.

PMID: 39410708 PMC: 11535291. DOI: 10.4062/biomolther.2024.148.


Prevalence and predictors of polypharmacy and comorbidities among patients with chronic obstructive pulmonary disease: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.

Alwafi H, Naser A, Ashoor D, Alsharif A, Aldhahir A, Alghamdi S BMC Pulm Med. 2024; 24(1):453.

PMID: 39272014 PMC: 11401255. DOI: 10.1186/s12890-024-03274-5.


References
1.
Kohansal R, Martinez-Camblor P, Agusti A, Buist A, Mannino D, Soriano J . The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009; 180(1):3-10. DOI: 10.1164/rccm.200901-0047OC. View

2.
Agusti A . COPD, a multicomponent disease: implications for management. Respir Med. 2005; 99(6):670-82. DOI: 10.1016/j.rmed.2004.11.006. View

3.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

4.
de Torres J, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli B . Gender and COPD in patients attending a pulmonary clinic. Chest. 2005; 128(4):2012-6. DOI: 10.1378/chest.128.4.2012. View

5.
Burgel P, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T . Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2008; 135(4):975-982. DOI: 10.1378/chest.08-2062. View